Articles

Filter by:
All Sectors
All Companies
Clear all filters
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
IMV immunotherapy for cancer
BTV
January 27, 2021

IMV Uses Proprietary Technology and Immune Systems to Kill Cancer Cells

IMV has its own proprietary technology, the DPX platform. “[Essentially] DPX is a delivery platform that has been specifically developed to generate a …

BTV
No items found.
No items found.